My Weird Prompts

Biologics for Severe Asthma: Beyond Singulair

32 min · 6 de jun de 2026
Portada del episodio Biologics for Severe Asthma: Beyond Singulair

Descripción

When inhaled corticosteroids, Singulair, and antihistamines fail, what's next? This episode maps the biologic and small-molecule landscape for severe asthma — anti-IgE, anti-IL-5, and anti-IL-4/IL-13 therapies. Learn how omalizumab, mepolizumab, benralizumab, and dupilumab target specific inflammatory mediators, how to match patients to the right biologic using biomarkers like IgE, eosinophils, and FeNO, and what practical factors — dosing frequency, comorbidities, lifestyle — tip the scales in clinical decision-making.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de My Weird Prompts!

Empezar

2 meses por 1 €

Después 4,99 € / mes · Cancela cuando quieras.

  • Podcasts exclusivos
  • 20 horas de audiolibros / mes
  • Podcast gratuitos

Todos los episodios

200 episodios

Portada del episodio Inside the AI Targeting Pipeline: Who Really Picks the Targets?

Inside the AI Targeting Pipeline: Who Really Picks the Targets?

The phrase "AI picks the targets" is both true and dangerously misleading. In this episode, we break down the real military targeting pipeline — from Project Maven to CENTCOM's new Prometheus system — and examine where artificial intelligence is actually making decisions. We explore the shift from AI-curated target banks (where humans define the pool) to AI-generated target banks (where the machine finds novel targets no human asked about). With case studies including Israel's "The Gospel" system generating 200 targets per day versus human analysts' 50 per year, we confront the uncomfortable reality of automation bias, twenty-second "reviews," and what happens when the human in the loop becomes a ceremonial rubber stamp.

9 de jun de 202629 min